Review




Structured Review

Epoch Life Signs Inc cas9 gene coding sequence
Screening of T. harzianum mutants resistant to 5′-FOA. ( A ) Schematic representation of vectors used to transform fungus spores. ( B ) Genomic DNA of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ) was isolated and screened by PCR for the presence of the <t>Cas9</t> gene which yielded a specific amplicon of 1242-bp. ( C ) Phenotype and growth of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ). *Bars marked with asterisk differ significantly ( P < 0.05). ( D ) A fragment from pyr4 , which was used for sequencing, confirmed mutants’ indels at target region. The sgRNA guiding sequence is highlighted in bold.
Cas9 Gene Coding Sequence, supplied by Epoch Life Signs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/cas9+gene+coding+sequence/pmc07806921-92-9-26
Average 90 stars, based on 1 article reviews
cas9 gene coding sequence - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system"

Article Title: Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system

Journal: Scientific Reports

doi: 10.1038/s41598-020-80186-4

Screening of T. harzianum mutants resistant to 5′-FOA. ( A ) Schematic representation of vectors used to transform fungus spores. ( B ) Genomic DNA of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ) was isolated and screened by PCR for the presence of the Cas9 gene which yielded a specific amplicon of 1242-bp. ( C ) Phenotype and growth of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ). *Bars marked with asterisk differ significantly ( P < 0.05). ( D ) A fragment from pyr4 , which was used for sequencing, confirmed mutants’ indels at target region. The sgRNA guiding sequence is highlighted in bold.
Figure Legend Snippet: Screening of T. harzianum mutants resistant to 5′-FOA. ( A ) Schematic representation of vectors used to transform fungus spores. ( B ) Genomic DNA of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ) was isolated and screened by PCR for the presence of the Cas9 gene which yielded a specific amplicon of 1242-bp. ( C ) Phenotype and growth of T. harzianum wild-type (WT) and FOA-resistant mutants ( ΔP3 , ΔP4 , ΔP7 , and ΔP13 ). *Bars marked with asterisk differ significantly ( P < 0.05). ( D ) A fragment from pyr4 , which was used for sequencing, confirmed mutants’ indels at target region. The sgRNA guiding sequence is highlighted in bold.

Techniques Used: Isolation, Amplification, Sequencing

Related Articles

CRISPR:

Article Title: Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system
Article Snippet: .. For the construction of the CRISPR/Cas9 editing system, the Cas9 gene coding sequence from S. pyogenes was codon-optimized for expression in Trichoderma harzianum and synthesized by Epoch Life Science, Inc. (Sugar Land, TX, USA) ( ). ..

Sequencing:

Article Title: Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system
Article Snippet: .. For the construction of the CRISPR/Cas9 editing system, the Cas9 gene coding sequence from S. pyogenes was codon-optimized for expression in Trichoderma harzianum and synthesized by Epoch Life Science, Inc. (Sugar Land, TX, USA) ( ). ..

Expressing:

Article Title: Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system
Article Snippet: .. For the construction of the CRISPR/Cas9 editing system, the Cas9 gene coding sequence from S. pyogenes was codon-optimized for expression in Trichoderma harzianum and synthesized by Epoch Life Science, Inc. (Sugar Land, TX, USA) ( ). ..

Synthesized:

Article Title: Generation of Trichoderma harzianum with pyr4 auxotrophic marker by using the CRISPR/Cas9 system
Article Snippet: .. For the construction of the CRISPR/Cas9 editing system, the Cas9 gene coding sequence from S. pyogenes was codon-optimized for expression in Trichoderma harzianum and synthesized by Epoch Life Science, Inc. (Sugar Land, TX, USA) ( ). ..



Similar Products

91
Addgene inc vector carrying ace2 coding sequences
Vector Carrying Ace2 Coding Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/ACE2+g1+%2B+Cas9+(Plasmid+%23153011)/pm40133950-166-13-23
Average 91 stars, based on 1 article reviews
vector carrying ace2 coding sequences - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

96
Addgene inc spcas9 coding sequences
Fig. 2 The modified 3TC scaffold boosts <t>SpCas9</t> gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001
Spcas9 Coding Sequences, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/SP-Cas9+(Plasmid+%2362731)/pm39939860-134-6-17
Average 96 stars, based on 1 article reviews
spcas9 coding sequences - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
Addgene inc cas9 coding sequence
Fig. 2 The modified 3TC scaffold boosts <t>SpCas9</t> gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001
Cas9 Coding Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/pUF-Cas9-pre-sgRNA+(Plasmid+%23137845)/pmc11779973-250-2-7
Average 93 stars, based on 1 article reviews
cas9 coding sequence - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

96
Addgene inc mouse zbp1 coding sequence
Fig. 2 The modified 3TC scaffold boosts <t>SpCas9</t> gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001
Mouse Zbp1 Coding Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/pCW-Cas9+(Plasmid+%2350661)/pm39300211-206-7-15
Average 96 stars, based on 1 article reviews
mouse zbp1 coding sequence - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Addgene inc spcas9 coding sequence
Fig. 2 The modified 3TC scaffold boosts <t>SpCas9</t> gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001
Spcas9 Coding Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+coding+sequence/SP-Cas9+(Plasmid+%2362731)/pmc11148721-351-12-21
Average 96 stars, based on 1 article reviews
spcas9 coding sequence - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

Image Search Results


Fig. 2 The modified 3TC scaffold boosts SpCas9 gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001

Journal: BMC genomics

Article Title: Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction.

doi: 10.1186/s12864-025-11317-2

Figure Lengend Snippet: Fig. 2 The modified 3TC scaffold boosts SpCas9 gRNA expression levels compared to the original 4T scaffold. (A) DNA sequence of the 4T and modified 3TC scaffolds. (B) Relative quantification (RQ) of mDmd gRNA delivered by nucleofection of PX459.V2 (4T) to C2C12 cells, by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Dunnett’s multiple comparisons test was performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001. (C, D, E) Comparison of the relative quantities of mDmd Sp gRNA, delivered by PX459.V2, pdg459.V2 (2 × 4T) and PX459.V3 (3TC), measured by qRT-PCR. Mean Log2RQ ± 95% CI; n = 3. One-way ANOVA with Tukey’s multiple comparisons test performed on ΔΔCT values, **p ≤ 0.01, ***p ≤ 0.001

Article Snippet: SaCas9Puro.V2 was generated by replacing the SpCas9 coding sequences of PX459.V2 with SaCas9 coding sequences from PX601 (Addgene #61591).

Techniques: Modification, Expressing, Sequencing, Quantitative Proteomics, Quantitative RT-PCR, Comparison

Fig. 5 Editing efficiencies of high-fidelity SpCas9s with the 3TC scaffold. Comparison of PX459.V2 SpCas9-HF1 (4T), PX459.V3 SpCas9-HF1 (3TC), PX459.V2 eSpCas9(1.1) (4T) and PX459.V3 eSpCas9(1.1) (3TC) plasmids de livered by lipofection at a (A) high and (B) low plasmid dose without puro mycin selection in HEK239T cells, assessed by deep amplicon sequencing. Mean ± SEM; n = 3. Two-way ANOVA with Šídák’s multiple comparisons test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (C) Editing efficiencies of hDMD-B in the G19 gRNA configuration with WT and high-fidelity Sp-Cas9 plasmids delivered by nucleofection with puromycin selection in HEK293Ts. Two- way ANOVA with Šídák’s multiple comparisons test; *p ≤ 0.05, ***p ≤ 0.001

Journal: BMC genomics

Article Title: Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction.

doi: 10.1186/s12864-025-11317-2

Figure Lengend Snippet: Fig. 5 Editing efficiencies of high-fidelity SpCas9s with the 3TC scaffold. Comparison of PX459.V2 SpCas9-HF1 (4T), PX459.V3 SpCas9-HF1 (3TC), PX459.V2 eSpCas9(1.1) (4T) and PX459.V3 eSpCas9(1.1) (3TC) plasmids de livered by lipofection at a (A) high and (B) low plasmid dose without puro mycin selection in HEK239T cells, assessed by deep amplicon sequencing. Mean ± SEM; n = 3. Two-way ANOVA with Šídák’s multiple comparisons test; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. (C) Editing efficiencies of hDMD-B in the G19 gRNA configuration with WT and high-fidelity Sp-Cas9 plasmids delivered by nucleofection with puromycin selection in HEK293Ts. Two- way ANOVA with Šídák’s multiple comparisons test; *p ≤ 0.05, ***p ≤ 0.001

Article Snippet: SaCas9Puro.V2 was generated by replacing the SpCas9 coding sequences of PX459.V2 with SaCas9 coding sequences from PX601 (Addgene #61591).

Techniques: Comparison, Plasmid Preparation, Selection, Amplification, Sequencing